These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3368632)

  • 1. [Prevention of infections in chronic bronchitis using vaccination and/or immunomodulation].
    Latil F; Arnaud A; Lagier F; Charpin J; Vervloet D
    Rev Mal Respir; 1988; 5(1):31-5. PubMed ID: 3368632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunologic stimulation in prevention of bacterial respiratory infection. Trial objective evaluation by changes in serum and sputum Ig(A and G)].
    Michel FB; d'Hinterland LD; Pinel AM; Guendon R; Guerrero A; Préault M
    Nouv Presse Med; 1975 Feb; 4(5):333-6. PubMed ID: 1093123
    [No Abstract]   [Full Text] [Related]  

  • 3. The prevention of severe lower respiratory infections in chronic bronchitis.
    Ruben FL
    Semin Respir Infect; 1989 Dec; 4(4):261-5. PubMed ID: 2697051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhalative immunostimulation in patients with chronic bronchitis].
    Kaspar P; Petro W
    Z Hautkr; 1988; 63 Suppl 4():64-6. PubMed ID: 3075383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic treatment of chronic bronchitis.
    Ruben FL
    Semin Respir Infect; 1988 Mar; 3(1):72-80. PubMed ID: 3283884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal vaccines for protection against respiratory and systemic bacterial infections.
    Oliveira ML; Arêas AP; Ho PL
    Expert Rev Vaccines; 2007 Jun; 6(3):419-29. PubMed ID: 17542756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral bacterial vaccines for the prevention of acute exacerbations in chronic obstructive pulmonary disease and chronic bronchitis.
    Arandjus C; Black PN; Poole PJ; Wood Baker R; Steurer-Stey C
    Respir Med; 2006 Oct; 100(10):1671-81. PubMed ID: 16934969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of bacterial respiratory infection by an association of bacterial ribosomes and membranous proteoglycans. 2. Objective assessment of the response and of the immunological stimulation.
    Michel FB; Dussourd d'Hinterland L; Pinel AM; Guendon R; Guerrero AJ; Moutou M; Bansard JP
    Arzneimittelforschung; 1980; 30(1a):198-206. PubMed ID: 6892780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy of chronic bronchitis: importance of humoral antibodies].
    Barandun S; Bauer W
    Schweiz Med Wochenschr; 1984 Jun; 114(25):887-90. PubMed ID: 6431609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of bacterial respiratory infection by a new vaccine, an association of bacterial ribosomes and membranous adjuvants. 1. General remarks.
    Michel FB; Dussourd d'Hinterland L
    Arzneimittelforschung; 1980; 30(1a):196-8. PubMed ID: 6892779
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preventive effect of an immunomodulator, OM-85 BV, on acute exacerbations of chronic bronchitis in elderly patients. Preliminary results at six months in 291 patients].
    Orcel B; Delclaux B; Baud M; Derenne JP
    Rev Mal Respir; 1993; 10(1):23-8. PubMed ID: 8451491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal polysaccharide vaccine. Recommendation of the Immunization Practices Advisory Committee.
    Ann Intern Med; 1982 Feb; 96(2):203-5. PubMed ID: 6277218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological prevention of bronchial infectious crisis among the persons suffering from chronic bronchitis. Theoretical bases and practical applications (author's transl)].
    Voisin C; Tonnel AB; Aerts C; Grigne P
    Acta Tuberc Pneumol Belg; 1975; 66(3):254-66. PubMed ID: 1211319
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of a new immunostimulating bacterial lysate in the prophylaxis of acute lower respiratory tract infections. A randomised, open, controlled clinical trial.
    Rossi S; Tazza R
    Arzneimittelforschung; 2004; 54(1):50-6. PubMed ID: 14979609
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immune preparation IRS-19 in the treatment of inflammation in the upper respiratory tracts].
    Gunchikov MV; Vinnikov AK
    Vestn Otorinolaringol; 2001; (1):40. PubMed ID: 11247247
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and immunologic test of the activity of a polymicrobial vaccine in patients with chronic bronchitis during a flare-up].
    Zanasi A; Tumietto F; Costigliola P; Ricchi E; Cacaci C; Cappelletti O; De Bernardi M
    Clin Ter; 1990 Mar; 132(5):321-8. PubMed ID: 2139835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of nasal application of CpG oligodeoxynucleotide as a mucosal adjuvant.
    Kodama S; Abe N; Hirano T; Suzuki M
    Laryngoscope; 2006 Feb; 116(2):331-5. PubMed ID: 16467729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral administration of "Infectvac" for prevention of acute respiratory tract infections].
    Luther P; Brachmann I; Werchan D; Wittig C; Tischner H
    Z Erkr Atmungsorgane; 1990; 175(2):95-9. PubMed ID: 2264367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
    Hickey DK; Aldwell FE; Beagley KW
    Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of bacterial vaccines in prevention of respiratory infections with special reference to pneumococcal vaccines.
    Huchon G
    Postgrad Med J; 1983; 59 Suppl 3():185-7. PubMed ID: 6647205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.